IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.81
+2.92%0
Insider buys (3m)
2
Insider sells (3m)
-$985.4K
Net value (3m)
-4.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 8, 2026 | Hata Yujiro S · director, officer: President and CEO | Sale | 25,538 | $37 |
| Oct 8, 2026 | Hata Yujiro S · director, officer: President and CEO | M-Exempt | 26,338 | $4.31 |
| Oct 8, 2026 | Hata Yujiro S · director, officer: President and CEO | Sale | 800 | $38 |
| Jul 9, 2026 | Ruiz Briseno Andres · officer: Chief Accounting Officer | M-Exempt | 9,550 | $13 |
| Jul 9, 2026 | Ruiz Briseno Andres · officer: Chief Accounting Officer | Sale | 9,550 | $40 |
| Jun 18, 2026 | ROSEN TERRY J · director | A-Award | 20,000 | $31 |
| Jun 18, 2026 | MACKEY CATHERINE J · director | A-Award | 20,000 | $31 |
| Jun 18, 2026 | Morrison Scott W · director | A-Award | 20,000 | $31 |
| Jun 18, 2026 | Hampton Malcolm Garret · director | A-Award | 20,000 | $31 |
| Jun 18, 2026 | Stein Jeffrey · director | A-Award | 20,000 | $31 |
| Jun 18, 2026 | YARNO WENDY L · director | A-Award | 20,000 | $31 |
| Mar 2, 2026 | Stein Jeffrey · director | Purchase | 50,000 | $33 |
| Feb 2, 2026 | WHITE MICHAEL ANTHONY · officer: Chief Scientific Officer | A-Award | 190,000 | $32 |
| Feb 2, 2026 | Bleharski Joshua · officer: Chief Financial Officer | A-Award | 170,000 | $32 |
| Feb 2, 2026 | Snyder Douglas B. · officer: SVP, General Counsel | A-Award | 1,041 | $17 |
| Feb 2, 2026 | Snyder Douglas B. · officer: SVP, General Counsel | A-Award | 1,039 | $17 |
| Feb 2, 2026 | Ruiz Briseno Andres · officer: See Remarks | A-Award | 1,253 | $17 |
| Feb 2, 2026 | Ruiz Briseno Andres · officer: See Remarks | A-Award | 682 | $23 |
| Feb 2, 2026 | Snyder Douglas B. · officer: SVP, General Counsel | A-Award | 130,000 | $32 |
| Feb 2, 2026 | Hata Yujiro S · director, officer: President and CEO | A-Award | 600,000 | $32 |
| Feb 2, 2026 | DORMAN STUART · officer: Chief Commercial Officer | A-Award | 155,000 | $32 |
| Feb 2, 2026 | Ruiz Briseno Andres · officer: See Remarks | A-Award | 80,000 | $32 |
| Feb 2, 2026 | Beaupre Darrin · officer: Chief Medical Officer | A-Award | 175,000 | $32 |
| Jun 26, 2025 | Morrison Scott W · director | A-Award | 20,000 | $22 |
| Jun 26, 2025 | MACKEY CATHERINE J · director | A-Award | 20,000 | $22 |
| Jun 26, 2025 | ROSEN TERRY J · director | A-Award | 20,000 | $22 |
| Jun 26, 2025 | YARNO WENDY L · director | A-Award | 20,000 | $22 |
| Jun 26, 2025 | Stein Jeffrey · director | A-Award | 20,000 | $22 |
| Jun 26, 2025 | Hampton Malcolm Garret · director | A-Award | 20,000 | $22 |
| Feb 28, 2025 | Snyder Douglas B. · officer: SVP, General Counsel | A-Award | 33,000 | $20 |
Institutional positioning
13F filings over the trailing two quarters
New 112Increased 178Reduced 167Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 14,109,431 | Aug 13, 2026 |
| FMR LLC | Increased | 13,172,103 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,893,260 | Aug 7, 2026 |
| Jupiter Topco LLC | New Position | 8,579,881 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 8,442,133 | May 13, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 7,265,253 | May 18, 2026 |
| Capital Research Global Investors | Increased | 5,344,701 | Aug 12, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Reduced | 5,163,543 | May 13, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 5,010,030 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4,548,911 | Sep 22, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,132,646 | Aug 13, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 3,946,515 | May 15, 2026 |
| STATE STREET CORP | Reduced | 3,781,167 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,732,422 | May 15, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | Reduced | 3,450,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 8, 2026